NEWS 06/24/1993
P93-27 Food and Drug Administration FOR IMMEDIATE RELEASE Mike Kubic -- (301) 443-4177 The Food and Drug Administration has taken a step to speed upreview of regulated products and improve internal communications byinstalling a state-of-the-art video-teleconferencing facility. The new facility is intended to speed up exchanges of views and information between the agency and manufacturers about new drugsand other regulated products submitted to the agency for review. In the past,such discussions usually required the product sponsors to bring to FDA headquarters sizable delegations of scientists and executives. Because of their size, the meetings took a long time to arrange and sometimesstill foundered on the absence of a key person. Videoconferencing also provides prompt access to authorities who cooperate with FDA in dealing with public health emergencies suchas product tampering or outbreaks of contagious diseases. "This equipment has a great potential for saving time insituations where time saved can mean saving human lives or preventing pain andsuffering," said FDA Commissioner David A. Kessler, M.D. "It's another step tobring the agency's review process and emergency operations up to optimumspeed." -MORE- Page 2, P93-27, Video-teleconferencing facility The conferencing facility, located at FDA headquarters inRockville, Md., is capable of communications with similarly- equipped establishments all over the world. It can bring togetheras many as 30 participants from each side for discussions that are generally expected to last 30 to 90 minutes. The equipment has abuilt-in encryption device that provides communication security forconfidential exchanges. In addition to conferences with other authorities and productsponsors,Ôh)0*0*0*°°ÔŒthe equipment will be used for internal FDA meetings, training andcontacts with the public. FDA is one of the eight Public Health Service agencies within HHS. ####